Stealth BioTherapeutics Corp (MITO)’s Financial Results Comparing With Zosano Pharma Corporation (NASDAQ:ZSAN)

Stealth BioTherapeutics Corp (NASDAQ:MITO) and Zosano Pharma Corporation (NASDAQ:ZSAN) compete against each other in the Biotechnology sector. We will compare them and contrast their risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and valuation.

Earnings & Valuation

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Stealth BioTherapeutics Corp N/A 0.00 96.71M -2.68 0.00
Zosano Pharma Corporation N/A 0.00 35.36M -9.39 0.00

Table 1 showcases the top-line revenue, earnings per share and valuation of Stealth BioTherapeutics Corp and Zosano Pharma Corporation.


Table 2 hightlights the net margins, return on assets and return on equity of the two companies.

Net Margins Return on Equity Return on Assets
Stealth BioTherapeutics Corp 0.00% 0% 0%
Zosano Pharma Corporation 0.00% -185.2% -116.3%


The Current Ratio and Quick Ratio of Stealth BioTherapeutics Corp are 0.1 and 0.1 respectively. Its competitor Zosano Pharma Corporation’s Current Ratio is 5.4 and its Quick Ratio is 5.4. Zosano Pharma Corporation can pay off short and long-term obligations better than Stealth BioTherapeutics Corp.

Analyst Ratings

The Ratings and Recommendations for Stealth BioTherapeutics Corp and Zosano Pharma Corporation are featured in the next table.

Sell Ratings Hold Ratings Buy Ratings Rating Score
Stealth BioTherapeutics Corp 0 0 2 3.00
Zosano Pharma Corporation 0 0 0 0.00

Stealth BioTherapeutics Corp’s upside potential is 97.72% at a $26 average price target.

Institutional and Insider Ownership

Institutional investors owned 0% of Stealth BioTherapeutics Corp shares and 53.9% of Zosano Pharma Corporation shares. Comparatively, insiders own roughly 1.97% of Zosano Pharma Corporation’s shares.


Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Stealth BioTherapeutics Corp 6.43% 0% 0% 0% 0% 7.06%
Zosano Pharma Corporation -4.91% 105.96% 25.39% 19.51% -11.36% 128.3%

For the past year Stealth BioTherapeutics Corp was less bullish than Zosano Pharma Corporation.


Stealth BioTherapeutics Corp beats Zosano Pharma Corporation on 4 of the 7 factors.

Zosano Pharma Corporation, a clinical stage pharmaceutical company, develops a proprietary intracutaneous delivery system to administer drugs through the skin for rapid symptom relief to patients. Its lead product candidate is M207, a proprietary formulation of zolmitriptan used for the treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.